Moleculin CEO, Walter Klemp, Highlights 45 Subject Enrollment Milestone in Recent Virtual Investor “What This Means” Segment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Moleculin CEO, Walter Klemp, Highlights 45 Subject Enrollment Milestone in Recent Virtual Investor “What This Means” Segment
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 3.12 +0.24 (8.33%)
Previous Close $2.88    52 Week High $9.58 
Open $3.01    52 Week Low $2.34 
Day High $3.16    P/E N/A 
Day Low $2.94    EPS $-0.34 
Volume 437,313